Topical Mastic Oil for Treatment of Functional Dyspepsia: A Randomized Triple-Blind Controlled Trial

被引:5
|
作者
Sattarzadeh, Mahsa Baradaran [1 ]
Shojaii, Asie [2 ]
Toosi, Mohssen Nassiri [3 ]
Abdollahi-Fard, Mehri [2 ]
Avanaki, Foroogh Alborzi [3 ]
Taher, Mohammad [3 ]
Shiehmorteza, Maryam [1 ]
Hashem-Dabaghian, Fataneh [2 ]
机构
[1] Islamic Azad Univ, Tehran Univ Med Sci, Fac Pharm & Pharmaceut Sci, Dept Clin Pharm, Tehran, Iran
[2] Iran Univ Med Sci, Sch Persian Med, Res Inst Islamic & Complementary Med, Tehran, Iran
[3] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Gastroenterol, Tehran, Iran
来源
GALEN MEDICAL JOURNAL | 2021年 / 10卷
关键词
Functional Dyspepsia; Persian Medicine; Herbal Medicine; Clinical Trial; Mastic; VALIDATION; DISORDERS; SEVERITY; SYMPTOMS; GUM;
D O I
10.31661/gmj.v10i0.1965
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The main goal of the present study was to evaluate the effect of topical mastic oil, compared to placebo on treatment of functional dyspepsia (FD). Materials and Methods: Sixty-three patients with FD were included. Thirty-two subjects received the topical mastic oil (10 drops/TDS after meal) with massage and 31 patients received topical sesame oil with massage. Both groups received pantoprazole (40 mg daily) along with oil and massage. The severity of early satiation, postprandial fullness, epigastric pain and epigastric burning was assessed after 4 weeks using the Visual Analogue Scale (VAS) as well as frequency of symptoms. Satisfaction with the treatment was also assessed using a researcher-made questionnaire. Changes in the severity of symptoms were evaluated by Friedman's test. Results: Mean and standard deviation of age of the subjects were equal to 36.95 +/- 13.64 and 50 (79.4%) patients were female. Both groups experienced a significant decrease in the severity of all the four symptoms (P<0.001). The percentage of decrease in the severity of early satiation was significantly higher in the mastic group than the control group (76.03 +/- 34.91% vs. 37.24 +/- 38.86%, P=0.003). No significant differences were found in the percentage of decrease in the severity of postprandial fullness, epigastric pain and burning between the study groups (P=0.05, 0.06, and 0.13, respectively). The frequency of symptoms was decreased similarly in both groups. Satisfaction with the treatment was reported to be significantly higher in the mastic group than the sesame group (P=0.01). There were no intolerable side effects in both groups. Conclusion: Mastic oil reduced early satiation better than the placebo. In addition, satisfaction with the treatment was higher in the mastic group than the sesame group.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics
    Talley, Nicholas J.
    Locke, G. Richard, III
    Herrick, Linda M.
    Silvernail, Vickie M.
    Prather, Charlene M.
    Lacy, Brian E.
    DiBaise, John K.
    Howden, Colin W.
    Brenner, Darren M.
    Bouras, Ernest P.
    El-Serag, Hashem B.
    Abraham, Bincy P.
    Moayyedi, Paul
    Zinsmeister, Alan R.
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (03) : 523 - 533
  • [42] Topical application of a cream containing nanoparticles with vitamin E for radiodermatitis prevention in women with breast cancer: A randomized, triple-blind, controlled pilot trial
    Queiroz Schmidt, Fernanda Mateus
    Serna Gonzalez, Carol Viviana
    Mattar, Rodrigo Calixto
    Lopes, Luciana Biagini
    Santos, Marinilce Fagundes
    Conceicao de Gouveia Santos, Vera Lucia
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2022, 61
  • [43] Treatment of functional dyspepsia with a herbal preparation - A double-blind, randomized, placebo-controlled, multicenter trial
    Madisch, A
    Holtmann, G
    Mayr, G
    Vinson, B
    Hotz, J
    DIGESTION, 2004, 69 (01) : 45 - 52
  • [44] THE EFFECT OF RIFAXIMIN ON STRESS SENSITIVITY: PRELIMINARY ANALYSIS OF A RANDOMIZED, TRIPLE-BLIND, PLACEBO CONTROLLED CLINICAL TRIAL
    Satriawan, Dina
    Raes, Jeroen
    Verbeke, Kristin
    Dalile, Boushra
    Van Oudenhove, Lukas
    PSYCHOSOMATIC MEDICINE, 2024, 86 (05): : A90 - A90
  • [45] Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? Comment on a randomized triple-blind placebo-controlled trial
    Kiumarth Amini
    Maryam Taghizadeh-Ghehi
    European Journal of Clinical Pharmacology, 2020, 76 : 607 - 608
  • [46] Effects of Viola odorata syrup on sleep quality in menopausal women: a randomized, triple-blind, controlled trial
    Karimi, Fatemeh Zahra
    Nazari, Nahid
    Lotfi, Fatemeh
    Mazloom, Seyed Reza
    Yousefi, Mahdi
    Rakhshandeh, Hassan
    SLEEP AND BREATHING, 2024, 28 (03) : 1137 - 1144
  • [47] Subacromial Corticosteroid Injection on Poststroke Hemiplegic Shoulder Pain: A Randomized, Triple-Blind, Placebo Controlled Trial
    Rah, Ueon Woo
    Yoon, Seung-Hyun
    Moon, Do Jun
    Kwack, Kyu-Sung
    Hong, Ji Yeon
    Lim, Yong Cheol
    Joen, Bohyun
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2012, 93 (06): : 949 - 956
  • [48] Erratum to: Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
    I. Giannini
    A. Amato
    L. Basso
    N. Tricomi
    M. Marranci
    G. Pecorella
    S. Tafuri
    D. Pennisi
    D. F. Altomare
    Techniques in Coloproctology, 2015, 19 : 665 - 666
  • [49] Effects of Perioperative Administration of Acetaminophen on Postoperative Shivering: A Randomized, Triple-Blind, Placebo-Controlled Trial
    Kinjo, Takehiro
    Tadokoro, Takahiro
    Tokushige, Akihiro
    Zamami, Taketo
    Taira, Sumire
    Ikehara, Yumi
    Tsuhako, Chiemi
    Ohtsu, Hiroshi
    Ueda, Shinichiro
    Kakinohana, Manabu
    ANESTHESIA AND ANALGESIA, 2020, 130 (04): : 983 - 990
  • [50] Comment on "Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? A randomized triple-blind placebo-controlled trial"
    Majdi, Alireza
    Alavi, Seyed Ahmad
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (04) : 609 - 610